glp-1 news today pharma health obesity drugs october 2025 Outlook for obesity in 2025: more GLP-1 Safety Check - National

Use of these drugs is much higher among adults who are currently covered by health insurance compared to those who are uninsured (12% v

By doing so, they enhance the same pathways that regulate appetite and glucose levels

Koh A, De Vadder F, Kovatcheva-Datchary P, Bckhed F

There is mounting evidence to suggest GLP-1 obesity treatments also help reduce cancer risk, according to several recent studies

J Endocrinol 222: 191200

The weight loss was great, but honestly, just feeling like myself again was the biggest win." These aren't overnight miraclesthey're the result of systematically addressing the underlying metabolic dysfunction driving PCOS